AAAAAA

   
Results: 1-20 |

Table of contents of journal:

Results: 20

Authors: Usatoff, V Habib, NA
Citation: V. Usatoff et Na. Habib, Hepatocellular carcinoma - The clinical problem, METH MOL M, 45, 2000, pp. 3-20

Authors: Riordan, SM Williams, R
Citation: Sm. Riordan et R. Williams, Medical management of hepatocellular carcinoma, METH MOL M, 45, 2000, pp. 21-34

Authors: Ishido, S Fujita, T Hotta, H
Citation: S. Ishido et al., Possible involvement of the NS3 protein of hepatitis C virus in hepatocarcinogenesis - Its interaction with the p53 tumor suppressor, METH MOL M, 45, 2000, pp. 37-55

Authors: Wang, XW
Citation: Xw. Wang, Abrogation of p53-induced apoptosis by the hepatitis B virus x gene, METH MOL M, 45, 2000, pp. 57-70

Authors: Vandelli, C Renzo, F
Citation: C. Vandelli et F. Renzo, Hepatocellular carcinoma - Role of hepatitis viruses and liver cell dysplasia, METH MOL M, 45, 2000, pp. 71-96

Authors: Brunetto, MR Otiveri, F Bonino, F
Citation: Mr. Brunetto et al., The impact of hepatitis B virus (HBV) and hepatitis C virus (HCV) - From research to clinical practice, METH MOL M, 45, 2000, pp. 99-112

Authors: Tullo, A Sbisa, E
Citation: A. Tullo et E. Sbisa, Mutation of p53 tumor suppressor gene in hepatocellular carcinoma, METH MOL M, 45, 2000, pp. 113-130

Authors: Ohene-Abuakwa, Y Pignatelli, M
Citation: Y. Ohene-abuakwa et M. Pignatelli, Diagnostic markers in hepatocellular carcinoma using immunohistochemical techniques, METH MOL M, 45, 2000, pp. 131-138

Authors: Musso, O Clement, B Theret, N
Citation: O. Musso et al., Assessing matrix metalloproteinase expression and activity in hepatocellular carcinomas, METH MOL M, 45, 2000, pp. 139-156

Authors: Wu, CG
Citation: Cg. Wu, Isolation of novel markers for hepatocellular carcinoma by a subtraction-enhanced display technique, METH MOL M, 45, 2000, pp. 157-165

Authors: Naka, T Kaneko, T Kaibara, N
Citation: T. Naka et al., Measurement of protein expression of p53, p21(WAF1), and Rb in patients with surgically treated hepatocellular carcinoma by using catalyzed signal-amplification system, METH MOL M, 45, 2000, pp. 167-173

Authors: Kaneko, S Tamaoki, T
Citation: S. Kaneko et T. Tamaoki, Gene therapy vectors harboring AFP regulatory sequences - Preparation of an adenoviral vector, METH MOL M, 45, 2000, pp. 177-187

Authors: Seth, P Higginbotham, J
Citation: P. Seth et J. Higginbotham, Advantages and disadvantages of multiple different methods of adenoviral vector construction, METH MOL M, 45, 2000, pp. 189-198

Authors: Sarraf, CE
Citation: Ce. Sarraf, Electron microscopic assessment of adenovirus-mediated transfer, METH MOL M, 45, 2000, pp. 199-206

Authors: Mitry, RR Kelly, MD Zhao, J Negishi, S Mansour, MR Habib, NA
Citation: Rr. Mitry et al., p53 plasmid preparation and techniques for analysis of gene transfer and expression, METH MOL M, 45, 2000, pp. 207-220

Authors: Liu, YJ Zhao, J Lu, Y Trojan, J Wu, MC Guo, YJ
Citation: Yj. Liu et al., Antisense IGF-I for hepatocellular carcinoma, METH MOL M, 45, 2000, pp. 221-235

Authors: Wei, LX Wang, H Liu, YJ Wu, MC Guo, YJ
Citation: Lx. Wei et al., Novel effective tumor vaccines for hepatocellular carcinoma, METH MOL M, 45, 2000, pp. 237-246

Authors: Chapoval, AI Zhu, GF Chen, LP
Citation: Ai. Chapoval et al., Immunoglobulin fusion proteins as a tool for evaluation of T-cell costimulatory molecules, METH MOL M, 45, 2000, pp. 247-255

Authors: Kanai, F Ohashi, M Marignani, PA Shiratori, Y Hamada, H Omata, M
Citation: F. Kanai et al., Adenovirus-mediated drug-sensitivity gene therapy for hepatocellular carcinoma, METH MOL M, 45, 2000, pp. 257-269

Authors: Kelly, MD Mitry, RR Habib, NA
Citation: Md. Kelly et al., Clinical protocol for p53 gene therapy for liver tumors, METH MOL M, 45, 2000, pp. 273-298
Risultati: 1-20 |